Aug 042016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, PA – Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced the appointment of Bill Humphries, the President and Chief Executive Officer of Merz North America, a division of Merz, Inc., to the Aclaris Board, effective September 1st.… => Read more

Aclaris Therapeutics announces Bill Humphries to the Board of Directors

From:: Aclaris Therapeutics announces Bill Humphries to the Board of Directors

 Posted by at 9:15 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: